Quantitative Ultrasound Spectroscopic Imaging for Characterization of Disease Extent in Prostate Cancer Patients

by Ali Sadeghi-Naini, Ervis Sofroni, Naum Papanicolau, Omar Falou, Linda Sugar, Gerard Morton, Martin J. Yaffe, Robert Nam, Alireza Sadeghian, Michael C. Kolios, Hans T. Chung, Gregory J. Czarnota
Published 2015-02-01

Adjuvant Versus Salvage Radiotherapy for Patients With Adverse Pathological Findings Following Radical Prostatectomy: A Decision Analysis

by Christopher J. D. Wallis MD, Gerard Morton MD, Angela Jerath MD, Raj Satkunasviam MD, Ewa Szumacher MD, Sender Herschorn MD, Ronald T. Kodama MD, Girish S. Kulkarni MD, David Naimark MD, Robert K. Nam MD
Published 2017-05-01

A Phase 2 Randomized Pilot Study Comparing High-Dose-Rate Brachytherapy and Low-Dose-Rate Brachytherapy as Monotherapy in Localized Prostate Cancer

by Lara Hathout, MD, FRCPC, Omar Mahmoud, MD, PhD, Yaqun Wang, PhD, Irina Vergalasova, PhD, Maroie Barkati, MD, FRCPC, Philippe Després, PhD, André-Guy Martin, MD, MSc, FRCPC, William Foster, MD, FRCPC, Frédéric Lacroix, PhD, Guila Delouya, MD, MSc, FRCPC, Daniel Taussky, MD, FRCPC, Gerard Morton, MD, FRCPC, Eric Vigneault, MD, MSc, FRCPC
Published 2019-10-01

Utilization of Salvage and Systemic Therapies for Recurrent Prostate Cancer as a Result of 18F-DCFPyL PET/CT Restaging

by Wei Liu, MD, Katherine Zukotynski, MD, PhD, FRCPC, Louise Emmett, MD, FRACP, Hans T. Chung, MD, FRCPC, Peter Chung, MD, FRCPC, Robert Wolfson, MD, FRCPC, Irina Rachinsky, MD, MSc, FRCPC, Anil Kapoor, MD, FRCSC, Ur Metser, MD, FRCPC, Andrew Loblaw, MD, MSc, FRCPC, Gerard Morton, MB, FRCPC, Tracy Sexton, MD, PhD, FRCPC, Michael Lock, MD, FRCPC, Joelle Helou, MD, MSc, Alejandro Berlin, MD, MSc, Colm Boylan, MB, FRCPC, Susan Archer, BSc, Gregory R. Pond, PhD, PStat, Glenn Bauman, MD, FRCPC
Published 2021-01-01